Open access · CC-BY
via OpenAlex
In Vivo Direct Reprogramming: Current Progress and Future Prospects from Mechanisms to Therapeutic Application
Rishabh Deo Singh, Mauro Calvoli, Kyeong Kyu Kim
Advanced Science · 2026
Abstract
Direct reprogramming, which converts somatic cells from one lineage to another without passing through a pluripotent state, represents a promising therapeutic strategy for regenerative medicine. Recent advancements in identifying reprogramming factors and understanding molecular barriers have enabled efficient generation of therapeutically relevant cells. Yet, the clinical application of in vitro-derived reprogrammed cells is hampered by the immature phenotype, hostile microenvironments, low engraftment, and poor survival after transplantation. In vivo direct reprogramming of tissue-resident cells within their native tissue microenvironment offers a compelling alternative to overcome these barriers. Harnessing biochemical and biophysical cues of the tissue microenvironment, this approach facilitates the acquisition of molecular and functional features resembling endogenous cells. This review summarizes the current understanding of in vivo direct reprogramming, covering mechanisms, key reprogramming factors, and delivery strategies, and explores therapeutic applications across organ systems. Finally, key challenges such as delivery efficiency, incomplete understanding of tissue cues, and limited mechanistic insights, along with emerging strategies, are discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/advs.77370
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Singh, R.D., Calvoli, M., & Kim, K.K. (2026). In Vivo Direct Reprogramming: Current Progress and Future Prospects from Mechanisms to Therapeutic Application. <em>Advanced Science</em>. https://doi.org/10.1002/advs.77370
Vancouver
Singh RD, Calvoli M, Kim KK. In Vivo Direct Reprogramming: Current Progress and Future Prospects from Mechanisms to Therapeutic Application. Advanced Science. 2026. doi:10.1002/advs.77370.
BibTeX
@article{rishabh2026InVivo,
title = {In Vivo Direct Reprogramming: Current Progress and Future Prospects from Mechanisms to Therapeutic Application},
author = {Rishabh Deo Singh and Mauro Calvoli and Kyeong Kyu Kim},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.77370},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Circulation Research 2023
Open access · OA
Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for Novel Therapies
Stem Cell Reviews and Reports 2022
Open access · CC-BY
The Mechanism of Stem Cell Aging
eScholarship (California Digital Library) 2019
Preprint · OA
Partial Reprogramming: A Shortcut to Rejuvenation
Korean journal of family medicine 2025
Open access · OA
Systemic aging delay and anti-aging therapy using allogeneic stem cells.
Tissue Engineering and Regenerative Medicine 2017
Open access · OA
Endogenous Stem Cells in Homeostasis and Aging
Bioengineering 2025
Open access · CC-BY